Amber Tong – Page 120 – Endpoints News

about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW

Amber Tong on LinkedIn

author articles

C4 Therapeutics bumps Andrew Phillips to CEO; Milind Deshpande exits Achillion; Leena Gandhi to head up I/O at Eli ...

8 years ago

In a comeback, Portola scores FDA accelerated approval for once-rejected Andexxa

8 years ago

After raising VC money weeks ago, Unity tacks on an $85M IPO; Abpro sets terms for $60M IPO

8 years ago

FDA motions Alnylam's lumasiran into a PhIII short track, setting up a shot at an OK in '20

8 years ago

Glass half empty: Achaogen receives split vote from FDA experts on lead antibiotic, shares plunge

8 years ago

Achillion's CEO Milind Deshpande steps down; NeuroVision raises $11.2M for novel Alzheimer's detection tech

8 years ago

Playing the long game in I/O, J&J inks $1.04B deal to buy oncolytic virus platform biotech BeneVir

8 years ago

Iterum tests public market's appetite for anti-infectives in $92M IPO

8 years ago

‘Biohacker’ Traywick dead at 28 — known for self-injecting a DIY herpes drug

8 years ago

Pfizer cuts five cancer programs; George Church engages Cellectis' TALEN tech to create virus-resistant human cells

8 years ago

Omega Funds leads $35M Series A to fuel Attenua's cough program, set for proof-of-concept this year

8 years ago

Ahead of Hong Kong listing changes, WuXi preps for a biotech boom with a new R&D center in Shanghai

8 years ago

Ex-AstraZeneca exec Lisa Anson to lead do-over at Redx; Advaxis shakes up C-suite

8 years ago

Achaogen earns $12M award for next-gen antibiotics; Endo acquires Somerset for $190M

8 years ago

Celldex brings out the ax in wake of breast cancer drug disaster, chopping a quarter of its staff

8 years ago

Arrested and charged with fraud, PixarBio CEO Frank Reynolds could face up to 20 years in prison

8 years ago

EMA committee recommends Alnylam's early-stage ATTR amyloidosis drug for orphan status

8 years ago

Hong Kong clears way for pre-revenue biotech IPOs, plans to accept listing applications by May

8 years ago

John Orwin tapped to lead Atreca; John Tsai takes Vas Narasimhan's old role at Novartis; Hal Barron nabs Genentech's ...

8 years ago

Biotech unicorn's 'brain' attracts a $115M mega-round as investors embrace AI upstart

8 years ago

Full FDA letter in hand, Solid Bio says it's working to reverse clinical hold on its DMD gene therapy

8 years ago

Novartis pledges $100M to malaria efforts; Lilly, Boehringer outlines new Jardiance kidney trial at Oxford

8 years ago

In light of Incyte's epacadostat debacle, NewLink scraps PhIII plans for its own IDO drug

8 years ago

Unencumbered by safety concerns, Roche's Hemlibra gets breakthrough status for new patient group

8 years ago

First page Previous page 117 118 119120121 122 123 Next page Last page